Home  >  Products  >  BBS2 (Bardet-Biedl syndrome 2) Blocking Peptide (the N terminal of BBS2)(100ug)
BBS2 (Bardet-Biedl syndrome 2) Blocking Peptide (the N terminal of BBS2)(100ug)

BBS2 (Bardet-Biedl syndrome 2) Blocking Peptide (the N terminal of BBS2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BBS2 Antibody(ARP59752_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59752
Size: 100ug
Weight: 80kDa
Gene: 583
Format: Lyophilized powder
Target: This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and mental retardation. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with six other BBS proteins.
Alternative names: BBS; MGC20703
See Full Product Listings >